Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer.

Euler AR, Bailey RJ, Zinny MA, Brandon ML, Rousseau B, Ferguson JP, Wood DR, Le VH.

Gastroenterology. 1989 Jul;97(1):98-103.

PMID:
2656368
2.

A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer.

Euler AR, Popiela T, Tytgat GN, Kulig J, Lookabaugh JL, Phan TD, Kitt MM.

Gastroenterology. 1989 Apr;96(4):967-71.

PMID:
2647578
3.

Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study.

Vantrappen G, Janssens J, Popiela T, Kulig J, Tytgat GN, Huibregtse K, Lambert R, Pauchard JP, Robert A.

Gastroenterology. 1982 Aug;83(2):357-63.

PMID:
7044880
4.

An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial.

Euler AR, Krawiec J, Odes H, Gilat T, Garcia L, Rachmilewitz D, Gabryelewicz A, Gibinski K, Bass D, Barbara L, et al.

Am J Gastroenterol. 1990 Feb;85(2):145-9.

PMID:
2405642
5.

Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Results of a multiclinic trial.

Euler AR, Tytgat G, Berenguer J, Brunner H, Wood DR, Lookabaugh JL, Phan TD.

Gastroenterology. 1987 Mar;92(3):604-7.

PMID:
3545965
6.

A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups.

Euler AR, Safdi M, Rao J, Jaszewski R, Welsh J, Le V, Raskin J, Fleischmann R, Razzaque M, Champion C, et al.

Gastroenterology. 1990 Jun;98(6):1549-57.

PMID:
2186951
7.

Failure of a cytoprotective dose of Arbacet to heal acute gastric ulcers.

Jaszewski R, Crane SA.

Am J Gastroenterol. 1988 Jul;83(7):734-6.

PMID:
3289379
8.

Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing.

Wengrower D, Fich A, Goldin E, Eliakim R, Ligumsky M, Rachmilewitz D.

Dig Dis Sci. 1987 Aug;32(8):857-60.

PMID:
3608733
9.

Effect of prostaglandin E2 and 15(R)15 methyl PGE2 on duodenal ulcer.

Chen FW, Leong RS, Ng PL, Karim SM.

Singapore Med J. 1980 Jun;21(3):596-8. No abstract available.

PMID:
7003723
10.

Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study.

Gilbert DA, Surawicz CM, Silverstein FE, Weinberg CR, Saunders DR, Feld AD, Sanford RL, Bergman D, Washington P.

Gastroenterology. 1984 Feb;86(2):339-45.

PMID:
6360786
11.
12.
13.

Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial.

Bright-Asare P, Sontag SJ, Gould RJ, Brand DL, Roufail WM.

Dig Dis Sci. 1986 Feb;31(2 Suppl):63S-67S.

PMID:
3080291
15.

Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.

Brand DL, Roufail WM, Thomson AB, Tapper EJ.

Dig Dis Sci. 1985 Nov;30(11 Suppl):147S-158S.

PMID:
3932048
16.

Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue.

Bright-Asare P.

Am J Med. 1986 Aug 18;81(2A):64-8.

PMID:
3092658
17.

[Efficacy and tolerability of enprostil in the treatment of duodenal ulcer. Comparison with cimetidine].

Frexinos J, Andrieu J, Evreux M, Guerre J, Michel H, Vicari F, Joubert M.

Gastroenterol Clin Biol. 1989;13(2):188-92. French.

PMID:
2496000
18.
20.

A therapeutic trial of 15 (R)-15-methyl prostaglandin E2 in rheumatoid arthritis patients with gastroduodenal lesions.

Simmons TC, Weinstein WM, Shapira M, Grossman MI.

Prostaglandins. 1981;21 Suppl:165-73.

PMID:
7029650
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk